Göttingen, Germany, 9 October 2020. As part of NextPharma’s ongoing strategy to continue to invest significantly in our existing sites, in order to both increase capacity and to improve efficiency with modern state-of-the-art equipment, we have recently completed a €15 million investment at our Goettingen site. The investment project, which was completed within 12 months, will expand our existing capacity in manufacturing and packaging of oral solid dosage forms in line with the highest quality and equipment standards.
Please click here to read the full English press release. Click here for the German version.